최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓醫學會誌 = Journal of Korean Oriental Medicine, v.32 no.4, 2011년, pp.83 - 99
이주관 (대전대학교 한의과대학 폐계내과학교실) , 양수영 (대전대학교 한의과대학 폐계내과학교실) , 김민희 (대전대학교 한의과대학 신경생리학교실) , 남궁욱 (대전대학교 한의과대학 신경생리학교실) , 박양춘 (대전대학교 한의과대학 폐계내과학교실)
Objective: This study aimed to evaluate the protective effects of Socheongryong-tang (SCRT) on elastase-induced lung injury. Materials and Methods: The extract of SCRT was treated to A549 cells and elastase-induced COPD mice model. Then, various parameters such as cell-based cytoprotective activity ...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
국내 성인의 만성폐쇄성폐질환 유병률은 어느정도인가? | 만성폐쇄성폐질환(Chronic Obstructive Pulmonary Disease; COPD)은 유해입자 또는 가스에 의한 비정상적 염증반응과 연관되어 비가역적인 기류제한이 나타나고 점차 진행하는 특징을 지닌 만성질환이다1). 우리나라 성인 유병률이 7.8%에 이르며2,3), 전 세계적으로 사망 원인 4위에 해당하는 주요 질병으로 예방과 치료에 대한 중요성이 점점 높아지고 있다4). 현재 COPD에 대한 약물치료는 증상을 완화하고, 급성 악화의 빈도를 감소시키며, 삶의 질과 운동 능력을 향상시키는 것을 목적으로 한다5). | |
만성폐쇄성폐질환이란 무엇인가? | 만성폐쇄성폐질환(Chronic Obstructive Pulmonary Disease; COPD)은 유해입자 또는 가스에 의한 비정상적 염증반응과 연관되어 비가역적인 기류제한이 나타나고 점차 진행하는 특징을 지닌 만성질환이다1). 우리나라 성인 유병률이 7. | |
한의학적으로 COPD는 어느 범주에 속하는가? | 말초기도의 폐쇄, 폐의 탄성 소실과 과도한 팽창, 환기 장애, 가스교환장애, 혈류장애의 특징을 갖는 COPD는 한의학의 咳而上氣하고 煩燥하는 肺脹證과 呼吸促急한 喘證 및 喉中有聲響하는 哮喘證의 범주에 속한다13). 이와 관련된 小靑龍湯의 효능에 대한 연구로는 실험동물을 이용한 연구들14-18,24)과 임상연구19-22)에서 그 유효성을 보고하고 있다. |
Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46.
Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005;172:842-7.
Korea National Statistical Office. Dajeon: Korea National Statistical Office; c1996-[cited 2009 Mar]. Available from: http://www.nso.go.kr
World Health Report. World Health Organization, Geneva. 2000. Available from URL: http://www.who.int/whr/2000/en/ statistics.htm.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55.
Lee DJ. The effects of Lonicera japonica on the murine model of Chronic obstructive pulmonary disease. Seoul: Kyung Hee Univ.; 2009.
Kim KT, Ko H. Effects of Shigyungbanha-tang on the lipopolysaccharide-induced acute lung injury in mice. Kor J Orient Physiol Pathol. 2009; 26:1349-1357.
Oh JS, Park YC. Protective effects of Gamipalmihwan on elastase-induced apoptosis of A549 cells. J Kor Orient Med. 2010;31(2):137-48.
Yoon JM, Park YC. Protective effects of Seonpyejeongcheon-tang on elastase-induced lung injury in mice. Kor J Orient Int Med. 2010;31(1):84-101.
장기. 중경전서. 서울: 행림출판사. 1977:460-1.
이상인. 방제학. 서울: 영림사. 1995:50.
전국한의과대학 폐계내과학교실. 동의폐계내과학. 서울: 한문화사. 2002:338-46.
Jung S, Cho SJ, Moon KI, Kim HW, Kim BY, Cho SI. Effects of Socheongryong-tang on immunoglobulin production in asthmatic mice. Kor J Herbology. 2008;23(1):23-8.
Kim KY, Lee JH, Kim YJ, Choi SY, Kim TH, Lyu YS, et al. Anti-allergic effects of Socheongyoung-tang on RBL-2H3 mast cell and mice-mediated allergy model. 2007;21(5):1260-70.
Kim HW. Effects of Socheongryong-tang on inflammatory cells in asthmatic mice. Kor J Orient Prevent Med Soc. 2006;10(2):121-9.
Jeong HJ, Hong MC, Shin MK, Bae HS. Sochungyong-tang, traditional Korean medicine, suppresses Th2 lineage development. Kor J Orient Physiol Pathol. 2005;19(2):380-8.
Jung JY, Jung HJ, Jung SK, Rhee HK. The inhibitory effects of Socheongryong-tang and Socheongryong-tang plus Sasam (Adenophorae Radix) on the IL-6, IL-8 and GM-CSF mRNA levels in human epithelial cells. J Kor Orient Med. 2003;24(1):74-83.
Hwang WS, Lee JS, Choi JY, Jung HJ, Rhee HK, Jung SK. Two cases of chronic sinusitis with asthma improved by Socheongryong-tang. J Kor Orient Med. 2003;24(1):207-12.
Jung SK, Heo TS, Hwang WS, Ju CY, Kim YW, Jung HJ. The effects of Socheongryong-tang on serum IL-4, IL-5, and IFN-r in asthmatic patients. J Kor Orient Med. 2002;23(2):70-7.
Hwang WS, Jung HJ, Ju CY, Lee JS, Lee KK, Rhee HK, et al. A study on changes in blood eosinophil, serum IgE and T lymphocyte subpopulation after Socheongryong-tang to asthmatic patients. Kor J Orient Int Med. 2002; 23(1):83-90.
Heo TS, Hwang WS, Ju CY, Jung HJ, Rhee HK, Jung SK. The effects of Socheongryong-tang on pulmonary function and quality-of-life in asthmatic patients. J Kor Orient Med. 2001;22(4):131-41.
Park YC. Effect of Socheongryong-tang on Punghan and Pungyeol type common cold: a double blind, placebo controlled study. Kor J Orient Physiol Pathol. 2005;19(2):524-9
Na DG, Lee CJ, Park YC. Effects of Socheongryong-tang and Kamichihyo-san on mucine secretion from airway goblet cells. Kor J Orient Physiol Pathol. 2004;18(3):734-9.
Kawakami M, Matsuo Y, Yoshiura K, Nagase T, Yamashita N. Sequential and quantitative analysis of a murine model of elastase-induced emphysema. Biol Pharm Bull. 2008;31:1434-8.
Nakajoh M, Fukushima T, Suzuki T, Yamaya M, Nakayama K, Sekizawa K, et al. Retinoic acid inhibits elastase-induced injury in human lung epithelial cell lines. Am J Respir Cell Mol Biol. 2003;28:296-304.
Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med. 1998;158:555-64.
Molfino NA, Jeffery PK. Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies. Pulm Pharmacol Ther. 2007;20(5):462-72.
Yoo CG. Pathogenesis and pathophysiology of COPD. Kor J Int Med. 2009;77:383-400.
Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis. 2008;12(4):361-7.
Harel S, Janoff A, Yu SY, Hurewitz A, Bergofsky EH. Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am Rev Respir Dis. 1980;122:769-73.
Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435-59.
Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD. 2004;1(2):255-77.
Cho HY, Kleeberger SR. Genetic mechanisms of susceptibility to oxidative lung injury in mice. Free Radic Biol Med. 2007;42:433-45.
Gardi C, Arezzini B, Martorana PA. Testing of compounds in models of pulmonary emphysema. Curr Med Chem. 2008;15:803-8.
Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:67-86.
Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997;277:2002-4.
Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med. 1996; 154:1290-5.
Foronjy R, D'Armiento J. The role of collagenase in emphysema. Respir Res. 2001;2:348-52.
Uhal BD. Cell cycle kinetics in the alveolar epithelium. Am J Physiol. 1997;272:L1031-L45.
Draetta G, Beach D. The mammalian cdc2 protein kinase: mechanisms of regulation during the cell cycle. J Cell Sci Suppl. 1989;12:21-7.
Draetta G. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem Sci. 1990;15:378-83.
Moreno S, Nurse P. Substrates for p34cdc2: in vivo veritas? Cell. 1990;61:549-51.
Norbury CJ, Nurse P. Control of the higher eukaryote cell cycle by p34cdc2 homologues. Biochim Biophys Acta. 1989;989:85-95.
Nigg EA. The substrates of the cdc2 kinase. Semin Cell Biol. 1991;2:261-70.
Nigg EA, Krek W, Peter M. Vertebrate cdc2 kinase: its regulation by phosphorylation and its mitotic targets. Cold Spring Harb Symp Quant Biol. 1991;56:539-47.
Enoch T, Nurse P. Coupling M phase and S phase: controls maintaining the dependence of mitosis on chromosome replication. Cell. 1991; 65:921-3.
Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci. 1996;19:463-89.
Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev. 2002;12:14-21.
Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 1996;74:589-607.
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326-31.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.